Buzz4Bio

This Congress will offer a unique opportunity to connect, exchange and engage in in-depth discussions within small groups around oncology in all its dimensions, guided by a central theme: “Beyond Borders.”

Immerse yourself for a day and a half in an explosive mix of a business convention (with its business meeting platform), conferences of interest, company presentations, an exhibition area, but above all informal networking (during evenings, breaks and lunches) dedicated to players in the field of oncology.

When we speak about borders, we do not mean geographical boundaries alone.
Indeed, the European Oncology Congress will be held in Belgium, at the heart of Europe. But the borders we aim to cross are, above all, disciplinary, scientific and technological — the very boundaries that can limit innovation and slow down progress.

Oncology will be explored in its broadest sense: from research and development to diagnostics, immunotherapy, cell therapy, radiotherapy, preventive and curative cancer vaccines, MedTech, imaging, bioproduction and beyond.

We will also delve into the transformative innovations shaping the future of cancer care: personalised oncology, immuno-oncology, translational research, combination therapies, bedside cell therapy, liquid biopsy, multi-omics precision medicine, CAR-T and next-generation antibody technologies, extracellular vesicles (VLPs), lentiviral platforms, exosomes, virosomes, oncolytic viruses, as well as the digital and AI-driven revolutions redefining the field.

The Congress will bring together a wide spectrum of stakeholders, including pharmaceutical companies, biotech firms, CDMOs, technology and service providers, academic and private researchers, universities, hospitals, and more.

The event will embody what Buzz4bio creates alongside its partners: a cross-disciplinary, diverse and convergent ecosystem — transdisciplinary, forward-looking, and at the cutting edge of innovation.

More info on Oncology vol.3 – Buzz4bio : événementiel pharma biotech